RxSight, Inc. (RXST) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Chief Financial Officer Question-and-Answer Session Mark Wilterding Yes, it was a good start to year in line with our expectations, maybe a little bit ahead. I think what was the most encouraging from our perspective was the stability we saw in LAL sales. And so that's something we've been looking for, for the last several quarters, and we saw some signs of that, both in the unit volumes themselves, but also in the utilization rates. I would say in terms of the last part of your question, the decision to no ...